AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16285996
Drug: Triflusal 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflusal 600 mg/day
Trial: 16285996
Drug: Triflusal 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflusal 900 mg/day
Trial: 10414671
Drug: Clonidine (3‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (3‐4 mcg/kg)
Trial: 489767
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indoprofen
Trial: 6776161
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg indoprofen
Trial: 17149760
Drug: chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chemotherapy with simultaneous weekly trastuzumab for 24 weeks (n = 29)
Trial: 17149760
Drug: both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: both treatment regimens
Trial: 15233841
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of resistance and all-round, functional training
Trial: 2154047
Drug: Proton beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton beam treatment
Trial: 30391389
Drug: High-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose heparin (100 IU/kg body weight administered in divided doses)
Trial: 30391389
Drug: Standard-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose heparin (50 IU/kg body weight)
Trial: 30391389
Drug: High-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose heparin (100 IU/kg body weight)
Trial: 25671951
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of 30 mg/kg tranexamic acid
Trial: 25671951
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of tranexamic acid
Trial: 22742439
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for insomnia (CBTI); details on dosage and duration not specified.
Trial: 15894479
Drug: Inhaled HFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled HFA beclomethasone (Ventolair)
Trial: 12515670
Drug: rhGH small
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH small dose (0.3 IU.kg(‐1).d(‐1))
Trial: 12515670
Drug: rhGH large
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH large dose (0.6 IU.kg(‐1).d(‐1))
Trial: 9488531
Drug: Glutamine dipeptide-enriched
RxNorm normalized name: Alanyl-glutamine dipeptide
DrugBank: Alanyl glutamine (DB11876)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine dipeptide-enriched total parenteral nutrition (TPN)
Trial: 9488531
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (1.5 g of amino acids kg(‐1) day(‐1))
Trial: 7999488
Drug: Midazolam 0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.06 mg kg‐1 i.m.
Trial: 7999488
Drug: Diazepam 0.2
RxNorm normalized name: diazepam 0.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.2 mg kg‐1 orally
Trial: 26436473
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of intravenous acetaminophen every 6 hours until ICU discharge, resolution of fever, cessation of antimicrobial therapy, or death
Trial: 26436473
Drug: Placebo every
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo every 6 hours until ICU discharge, resolution of fever, cessation of antimicrobial therapy, or death
Trial: 16343858
Drug: Teicoplanin 800
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 800 mg pre-operatively (Group A)
Trial: 16343858
Drug: Teicoplanin 400
RxNorm normalized name: Teicoplanin 400 mg powder for solution for injection vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 400 mg pre-operatively plus two doses of 200 mg 24 h apart (Group B)
Trial: 12544006
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (40 g of alcohol daily for 3 weeks)
Trial: 12544006
Drug: Beer (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beer (40 g of alcohol daily for 3 weeks)
Trial: 12544006
Drug: Spirits (Dutch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirits (Dutch gin) (40 g of alcohol daily for 3 weeks)
Trial: 8726169
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (other anti-platelet drugs and/or warfarin potassium)
Trial: 2874411
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil (CMF)
Trial: 24035369
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional treatment (control)
Trial: 2874411
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant chemotherapy with CMF
Trial: 25948674
Drug: Topical saffron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical saffron (Crocus sativus L) gel
Trial: 23620937
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at Sifeng (EX-UE 10), treatment given once a week for 4 weeks.
Trial: 23620937
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group with erkangning syrup, administered 3 times a day for 4 weeks.
Trial: 25562712
Drug: Oxandrolone (Ox)
RxNorm normalized name: Oxandrolone
DrugBank: Oxandrolone (DB00621)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxandrolone (Ox) 0.03 mg/kg/day
Trial: 25562712
Drug: Oxandrolone (Ox)
RxNorm normalized name: Oxandrolone
DrugBank: Oxandrolone (DB00621)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxandrolone (Ox) 0.06 mg/kg/day
Trial: 20814189
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone + Oxandrolone (Ox) / Placebo (Pl)
Trial: 18360665
Drug: FRILJET local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FRILJET local cryoanesthesia and pulp vitality test agent
Trial: 12920470
Drug: Intravaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal misoprostol (25 g every 4 hours, not exceeding 8 doses)
Trial: 12920470
Drug: Intravenous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous oxytocin (continuous infusion)
Trial: 7939948
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg mebendazole (locally produced)
Trial: 7939948
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg mebendazole (original)
Trial: 7939948
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg mebendazole (original)
Trial: 7939948
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg albendazole (original)
Trial: 27611039
Drug: 25 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 μg dexmedetomidine
Trial: 27611039
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg dexmedetomidine
Trial: 27611039
Drug: 75 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 μg dexmedetomidine
Trial: 25555183
Drug: 8-week stress
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 8-week stress management program (10 min diaphragmatic breathing and 15 min progressive muscle relaxation twice per day)
Trial: 20693886
Drug: C1‐esterase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C1‐esterase inhibitor (100 U/kg)
Trial: 18842789
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg quercetin
Trial: 18842789
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg (‐)‐epicatechin
Trial: 18842789
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg epigallocatechin gallate
Trial: 8768870
Drug: GH/IGF‐I treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH/IGF‐I treatment (0.34 mg GH twice daily and 5.0 mg IGF‐I twice daily)
Trial: 8768870
Drug: GH/IGF‐I treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH/IGF‐I treatment
Trial: 3908494
Drug: Metronidazole (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (250 mg, 1 tablet 3 times per day for 5 days)
Trial: 31486700
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of fluvastatin daily for 6 weeks
Trial: 27990769
Drug: Brushing from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brushing from the buccal aspect
Trial: 27016644
Drug: ENG implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ENG implant
Trial: 22971985
Drug: Occupational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational Therapy (OT) - cooking activities once a week for 15 weeks
Trial: 20462664
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg of ustekinumab
Trial: 20462664
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg of ustekinumab
Trial: 18573392
Drug: High-dose insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose insulin therapy (5 mU/kg/min) with dextrose 20% to maintain blood glucose levels between 70 and 110 mg/dL (group II)
Trial: 18573392
Drug: Intraoperative intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative intravenous insulin infusion, titrated to maintain blood glucose concentrations less than 180 mg/dL (group I)
Trial: 16143197
Drug: Latanoprost intratympanic
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Latanoprost intratympanic injection (once daily for 3 days)
Trial: 16143197
Drug: Placebo intratympanic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo intratympanic injection
Trial: 10618936
Drug: Intra-articular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular morphine 1 mg
Trial: 10618936
Drug: Intra-articular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular morphine 4 mg
Trial: 6406705
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids alone (1.4 g/kg/day)
Trial: 6406705
Drug: Amino acids
RxNorm normalized name: Amino acids
DrugBank: Amino acids (DB09393)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acids (1.4 g/kg/day) plus 5% dextrose
Trial: 27102812
Drug: blended Cognitive
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: blended Cognitive Behavioural Therapy (bCBT) combining face-to-face and online sessions over 19-20 weeks
Trial: 27102812
Drug: blended Cognitive
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: blended Cognitive Behavioural Therapy (bCBT)
Trial: 24399768
Drug: Puerh tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Puerh tea extract capsule (333 mg Puerh tea extract) three times a day
Trial: 21073130
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (primary conventional treatment alone)
Trial: 17668232
Drug: 5,000 IU
RxNorm normalized name: bleopmycin 15,000 IU Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,000 IU rHuEpo every second day for 14 days, followed by a single dose of 5,000 IU weekly for 10 weeks
Trial: 9813955
Drug: Methylphenidate (fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (fixed dose for at least 1 month)
Trial: 8106759
Drug: Intranasal live
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal live cold-adapted (ca) influenza A vaccine
Trial: 8106759
Drug: Intramuscular trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular trivalent inactivated (triv) influenza vaccine
Trial: 1131627
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of primidone and phenytoin
Trial: 31059418
Drug: 9 months
RxNorm normalized name: treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 9 months of twice‐weekly isoniazid (9H)
Trial: 31059418
Drug: 12 once‐weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 once‐weekly doses of isoniazid and rifapentine (3HP)
Trial: 28733656
Drug: Glucocorticoid and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid and cyclophosphamide (50-100 mg per day)
Trial: 28733656
Drug: Prednisone monotherapy
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone monotherapy (0.5-1.0 mg/kg.d, tapered gradually)
Trial: 21742284
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil applied to abdominal skin area twice a day until the end of the study term
Trial: 16884439
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitors (SSRI) treatment for 12 weeks
Trial: 11402106
Drug: Interferon beta-1a,
RxNorm normalized name: INTERFERON BETA-1A,RECOMBINANT
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a, 44 microg three times weekly for 3 years
Trial: 11402106
Drug: Interferon beta-1a,
RxNorm normalized name: INTERFERON BETA-1A,RECOMBINANT
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a, 22 microg three times weekly for 3 years
Trial: 9230722
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (FM) 24 micrograms twice daily for 4 weeks
Trial: 9230722
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (FM) + oral prednisolone 50 mg
Trial: 9230722
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (FM)
Trial: 9230722
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (FM) + systemic corticosteroid
Trial: 8501271
Drug: 0.5% delmopinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% delmopinol HCl (aqueous solution)
Trial: 2945499
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg loratadine
Trial: 2945499
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg loratadine
Trial: 2960701
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg descarboethoxyloratadine
Trial: 2960701
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg descarboethoxyloratadine
Trial: 2960701
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg descarboethoxyloratadine
Trial: 19959537
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low cerebral blood volume (VLCBV) with a cutpoint at 2 mL and <2.5th percentile threshold
Trial: 14510091
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose povidone-iodine
Trial: 10768517
Drug: Cefepime +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime + Metronidazole (2 g cefepime + 500 mg metronidazole)
Trial: 10768517
Drug: Ceftriaxone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone + Metronidazole (2 g ceftriaxone + 500 mg metronidazole)
Trial: 8777468
Drug: ANF (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ANF (all doses)
Trial: 1325989
Drug: Prostaglandin-F2 alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin-F2 alpha instillation into the solitary tube and systemic prostaglandin administration
Trial: 1325989
Drug: Prostaglandin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin treatment for tubal pregnancy
Trial: 6664677
Drug: 1% betaxolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% betaxolol ophthalmic solution
Trial: 30669763
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose group (100 kV + ASIR)
Trial: 30669763
Drug: Normal dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal dose group (120 kV + FPP)
Trial: 30669763
Drug: Normal dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal dose group (120 kV + FBP)
Trial: 26446330
Drug: Midazolam (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.05 mg/kg bolus, 0.02‐0.1 mg/kg/hr infusion)
Trial: 26446330
Drug: Propofol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1 mg/kg bolus, 1‐3 mg/kg/hr infusion)
Trial: 17512147
Drug: Tablet A
RxNorm normalized name: tablet administration aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet A
Trial: 17512147
Drug: Tablet B
RxNorm normalized name: Biaxin 4 Tablet Blister Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet B
Trial: 17542016
Drug: Capsule
RxNorm normalized name: CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule
Trial: 16335333
Drug: Valerian-hops combination
RxNorm normalized name: HOPS
DrugBank: Hops (DB10687)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valerian-hops combination (2 nightly tablets for 28 days, n = 59)
Trial: 16335333
Drug: Diphenhydramine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (2 tablets of 25 mg for 14 days followed by placebo for 14 days, n = 60)
Trial: 16335333
Drug: Valerian-hops combination
RxNorm normalized name: HOPS
DrugBank: Hops (DB10687)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valerian-hops combination (n = 59)
Trial: 2178660
Drug: Ibuprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (400 mg and 800 mg)
Trial: 2178660
Drug: Frusemide (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (administered after baseline measurements)
Trial: 28345790
Drug: Acyl ghrelin
RxNorm normalized name: gellan gum (low acyl)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyl ghrelin infusion (1 pmol kg-1 min-1)
Trial: 26444729
Drug: Daclizumab HYP
RxNorm normalized name: Daclizumab
DrugBank: Daclizumab (DB00111)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclizumab HYP (150 mg subcutaneously every 4 weeks)
Trial: 26444729
Drug: Interferon beta-1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a (30 μg intramuscularly once weekly)
Trial: 19752420
Drug: 1-mg intravitreal
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-mg intravitreal triamcinolone
Trial: 19752420
Drug: 4-mg intravitreal
RxNorm normalized name: ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-mg intravitreal triamcinolone
Trial: 16924272
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) 3.2 g/day for 6 months
Trial: 1123897
Drug: Sorbitol infusion
RxNorm normalized name: Sorbitol
DrugBank: Sorbitol (DB01638)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sorbitol infusion at 0.125 g/kg/h
Trial: 1123897
Drug: Sorbitol infusion
RxNorm normalized name: Sorbitol
DrugBank: Sorbitol (DB01638)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sorbitol infusion at 0.25 g/kg/h
Trial: 31003654
Drug: Lavender oil
RxNorm normalized name: Lavender oil
DrugBank: Lavender oil (DB14566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lavender oil inhalation (1:10 ratio of lavender and sweet almond oil)
Trial: 31003654
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no lavender oil inhalation)
Trial: 21870630
Drug: Low-calorie diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calorie diet including 30 g day(‐1) of soy protein